Form 4: Orthofix Medical Inc. Executive Lucas Vitale Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Lucas Vitale, CP&BOO of Orthofix Medical Inc., sold 4,287 shares of common stock on March 18, 2025, to cover tax withholding obligations related to the settlement of restricted stock units.
Summary
- On March 18, 2025, Lucas Vitale, CP&BOO of Orthofix Medical Inc., sold 4,287 shares of common stock at a price of $16.6 per share.
- The sale was executed to satisfy tax withholding obligations related to the settlement of restricted stock units.
- This transaction was conducted under a pre-existing sell-to-cover requirement approved by the Compensation and Talent Development Committee.
- Following the transaction, Vitale directly owns 135,317 shares, which includes 123,894 restricted stock units.
Sentiment
Score: 6
Explanation: The document reflects a routine transaction (sale of shares for tax obligations) and doesn't suggest any significant positive or negative sentiment. It's a neutral event.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and are generally not indicative of a negative outlook on the company.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 03/18/2025 | Date of stock sale transaction. |
| 03/20/2025 | Date of signature on the Form 4 filing. |
Keywords
Orthofix Medical Inc., Lucas Vitale, stock sale, Form 4, restricted stock units, tax withholding, OFIX, CP&BOO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.